Marianne Albers

Marianne Albers


Phone: +55 (11) 3141-9108

City: São Paulo

Language: Portuguese, English and German

Linkedin: Marianne Albers

Practice Areas:

  • Infrastructure
  • Life Sciences
  • Public and Regulatory


Marianne is the partner in charge of the firm’s Public and Regulatory Law and Life Sciences departments.

Through her career, she has represented companies before certain principal Brazilian regulatory agencies such as the National Agency of Electrical Energy (ANEEL), the National Telecommunications Agency (ANATEL) and the Ministry of Agriculture, Livestock and Supply (MAPA), having led contract negotiations with government agencies, participated in high-profile bidding processes, and represented clients in administrative and court cases involving matters related to administrative and regulatory law.

In the area of Life Sciences, Marianne has accumulated vast experience in providing strategic counselling and in representing both Brazilian and foreign companies before the National Health Surveillance Agency (ANVISA), the National Health Agency (ANS), several local health surveillance agencies and health authorities in general. She assists clients throughout the registration process of medications and healthcare products and in obtaining operational licenses, special permits, and permits issued by the local health surveillance authorities. Marianne is recognized by Chambers and Partners (Band Four for Life Sciences), The Legal 500, Leaders League, Análise Advocacia, Análise Mulher and IFLR 1000.

Professional Associations

  • Admitted to the São Paulo branch of the Brazilian Bar Association (OAB/SP)


  • Specializations in Contracts and Civil Liability and Corporate Law, UFRGS – Universidade Federal do Rio Grande do Sul
  • LL.B., UFRGS – Universidade Federal do Rio Grande do Sul


Her recent experience includes advising:

  • Partners in structuring an innovative healthtech business together with an incubator;
  • A company specializing in integrated therapy solutions for advanced wound treatment, non-invasive compression therapy and orthopedics, in the divestment of a manufacturer of textile hospital consumables; and
  • A leading health plan provider in claims by the Federal Government and ANS to reimburse the Unified Health System (SUS).

Related articles